Clinical value of combined determination of serum and pleural effusion level of CEA,CYFRA21-1,TPS in the diagnosis of lung cancer;

Combined detection of γ-IFN, ADA and β_2-MG for differentiation of tuberculous pleural effusions;

Diagnostic Value of p53 and K-ras gene mutation of pleural effusions in lung cancer;

The clinical effect of streptococcus combined cisplatin on patients with cancer accompanied severe hydrothorax;

Differentiation Diagnosis Value for Comnined Measuring of ET,FN,CEA in Hydrothorax and Serum in Benign and Malignant Hydrothorax;

Application of detection of cytology and CYFRA-21 in diagnosis of hydrothorax;

Ultrastructural diagnosis of adenocarcinoma cells in pleural fluid of patients with lung cancer;

Comparative study on therappeutic effect between two-route thermo-chemotherapy and conventional chemotherapy for lung adenocarcinoma with pleural fluid;

Differential diagnosis of pleural fluid by multivariate logistic analysis;

Methods The concentration of RANTESin serum and pleural effusions samples from 22 tuberculous and 15 patients were determined by enzyme-labeled immunerbent assay(ELISA) and were compared with healthy donors.

Study of pingyangmycin combined with weierben intracavitary administration on gerontel malignant pleural fluid;

Clinical efficacy of local hyperthermia combined with Sodium Cantharidate injection and Cisplatin infused in thorax in treatment of malignant pleural fluid;